Building from a Solid Foundation: The Future of MedTech in Australia - Specialised Therapeutics

• by Specialised Therapeutics
• 0 Comments

ST has featured in the latest MedTech Sector report published by financial services and corporate advisory firm RSM. Turn to pages 16 and 17 where CEO Carlo Montagner discusses our business model, licensing strategy and future plans. Click on the magazine below to read the article.